Skip to main content
OpenTrials
Completed

NCT Number: NCT06585046

Pancreatic Surgery and Risk Factors

The goal of this observational study is to learn about post-pancreatic surgery diabetes mellitus(PCRD).The main questions it aims to answer are:

1. What are the clinical characteristics of PCRD? 2. What are the related factors for PCRD? All patients with pancreatic surgery have been given standardized treatment fot the condition.

The researchers will summarize the risk factors for PCRD from the PCRD group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pancreatic Surgey Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

About this study

Sponsors retrospectively collected data from patients with pancreatic surgery in Changzheng centers between January 2017 and June 2024.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years and <80 years, male or female; 2. Patients who underwent pancreatic resection in pancreaticobiliary surgery since January 2017 3. Those who have previously completed a cohort study in pancreaticobiliary surgery and signed informed consent; 4. Those who have completed and banked serum specimens and pathology specimens in our hospital.

-

Exclusion criteria

  • Age <18 years or ≥80 years; 2. Those with preoperative fasting blood glucose ≥5.8 mmol/l or HbA1c ≥6.0% or a history of diabetes; 3. Those with missing relevant data.

-

Treatment and study plan

Pancreatic surgery

Procedure

patients who did pancreas-related surgery

Primary outcomes

  1. Incidence of glycaemic disorders（prevalence of diabetes） (postoperative fasting blood glucose/HbA1C)

    Time frame: (within 5 years after surgery)

    The main objective of this study was the incidence of glucose metabolism disorders in patients treated with pancreatic surgery in our centre.

Secondary outcomes

  1. overall survival

    Time frame: within 5 years after surgery

  2. Disease-Free Survival

    Time frame: within 5 years after surgery

Sponsors and collaborators

Lead sponsor

Shanghai Changzheng Hospital

Other

Registry information

Official study title

The Risk Factors and Prognosis of Hyperglycemia Secondary to Pancreatic Surgery

Important dates

Study start
2017
Primary completion
2024
Study completion
2024
First posted
Sep 5, 2024
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.